Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03083145 · ClinicalTrials.gov registry record · NA
Protein Source, Nutrition Messaging, and Food Intake
A NA study of Obesity, sponsored by University of Arkansas, Fayetteville.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03083145: Completed NA study of Obesity, sponsored by University of Arkansas, Fayetteville.
NCT03083145 is a NA study of Obesity that has completed, run by University of Arkansas, Fayetteville. The registered enrollment target is 40 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03083145, a NA study of Obesity, has completed, sponsored by University of Arkansas, Fayetteville.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine how the protein source and the physical form of food consumed at breakfast impact food intake. Research will be conducted by assessing feelings of hunger, food preference and blood glucose in healthy adults following the ingestion protein-based (animal versus plant) drinks similar calorie and protein content.
Primary Outcome
Appetite was assessed using visual analog scales
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Whey Protein Beverage
- DIETARY_SUPPLEMENT Pea Protein Beverage
- BEHAVIORAL Snack Tray Choices
Study Locations (1)
Arkansas
- University of Arkansas - Fayetteville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2016-06-01 |
| Phase | NA |
What the finished NCT03083145 record still lists
NCT03083145 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Whey Protein Beverage is the first listed.
NCT03083145 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT03083145 about?
NCT03083145 is a clinical study titled "Protein Source, Nutrition Messaging, and Food Intake". The objective of this study is to determine how the protein source and the physical form of food consumed at breakfast impact food intake. Research will be conducted by assessing feelings of hunger, food preference and blood glucose in healthy adults following the ingestion protein-based (animal ver...
What is the current status of trial NCT03083145?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-02-01. Estimated completion is 2016-06-01.
What conditions does trial NCT03083145 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT03083145?
The interventions under investigation include: Whey Protein Beverage (DIETARY_SUPPLEMENT), Pea Protein Beverage (DIETARY_SUPPLEMENT), Snack Tray Choices (BEHAVIORAL).
Who is sponsoring clinical trial NCT03083145?
This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03083145 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03083145's enrollment target sits among peer trials
40 778th of 1053 higher than 249 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI